Literature DB >> 23351651

Within-patient emergence of the influenza A(H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway.

R Rykkvin1, A Kilander, S G Dudman, O Hungnes.   

Abstract

The association between a particular mutation in the HA1 subunit of the influenza virus haemagglutinin, D222G, and severe and fatal disease in cases of influenza A(H1N1)pdm09 in Norway during the 2009 pandemic was investigated using pyrosequencing. The prevalence of the variant among fatal cases was 8/26 and among severe non-fatal cases 5/52. No D222G mutations were found among the 381 mild cases. This difference could not be attributed to sampling differences, such as body location of sampling, or duration of illness. In cases with mutant virus where clinical specimens from different days of illness were available, transition from wild-type to mutant virus was commonly observed (4/5), indicating that the mutant virus emerged sporadically in individual patients. In patients with paired samples from both the upper and lower respiratory tract (n=8), the same viral genotypes were detected in both locations. In most of the D222G cases (11/13), the mutant virus was found as a quasispecies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23351651

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  15 in total

1.  Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.

Authors:  Charlene Ranadheera; Mable W Hagan; Anders Leung; Brad Collignon; Todd Cutts; Steven Theriault; Carissa Embury-Hyatt; Darwyn Kobasa
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

2.  Targeting Importin-α7 as a Therapeutic Approach against Pandemic Influenza Viruses.

Authors:  Patricia Resa-Infante; Duncan Paterson; Jaume Bonet; Anna Otte; Baldo Oliva; Ervin Fodor; Gülsah Gabriel
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

3.  Increased virulence of neuraminidase inhibitor-resistant pandemic H1N1 virus in mice: potential emergence of drug-resistant and virulent variants.

Authors:  Min-Suk Song; Yun Hee Baek; Eun-Ha Kim; Su-Jin Park; Semi Kim; Gyo-Jin Lim; Hyeok-Il Kwon; Philippe Noriel Q Pascua; Arun G Decano; Byeong-Jae Lee; Young-Il Kim; Richard J Webby; Young-Ki Choi
Journal:  Virulence       Date:  2013-08-02       Impact factor: 5.882

4.  Influenza A/H1/N1/09 infection in patients with cirrhosis has a poor outcome: a case series.

Authors:  Chinmaya Kumar Bal; Vikram Bhatia; Sachin Kumar; Deepak Saini; Vikas Khillan; Ekta Gupta; Neha Rathor; Ashok Choudhury; Naveen Kumar; Ripu Daman; Shiv Kumar Sarin
Journal:  Indian J Gastroenterol       Date:  2014-01-29

5.  Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.

Authors:  Kelsey R Florek; Jason T Weinfurter; Sinthujan Jegaskanda; Joseph N Brewoo; Tim D Powell; Ginger R Young; Subash C Das; Masato Hatta; Karl W Broman; Olav Hungnes; Susanne G Dudman; Yoshihiro Kawaoka; Stephen J Kent; Dan T Stinchcomb; Jorge E Osorio; Thomas C Friedrich
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

6.  One health, multiple challenges: The inter-species transmission of influenza A virus.

Authors:  Kirsty R Short; Mathilde Richard; Josanne H Verhagen; Debby van Riel; Eefje J A Schrauwen; Judith M A van den Brand; Benjamin Mänz; Rogier Bodewes; Sander Herfst
Journal:  One Health       Date:  2015-12-01

7.  Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Authors:  Kristin G-I Mohn; Rebecca Jane Cox; Gro Tunheim; Jan Erik Berdal; Anna Germundsson Hauge; Åsne Jul-Larsen; Bjoern Peters; Fredrik Oftung; Christine Monceyron Jonassen; Siri Mjaaland
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

8.  A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection.

Authors:  Tina Ruggiero; Francesco De Rosa; Francesco Cerutti; Nicole Pagani; Tiziano Allice; Maria L Stella; Maria G Milia; Andrea Calcagno; Elisa Burdino; Gabriella Gregori; Rosario Urbino; Giovanni Di Perri; Marco V Ranieri; Valeria Ghisetti
Journal:  Influenza Other Respir Viruses       Date:  2013-08-09       Impact factor: 4.380

9.  Analysis of adaptation mutants in the hemagglutinin of the influenza A(H1N1)pdm09 virus.

Authors:  Alicia Jiménez-Alberto; Esmeralda Alvarado-Facundo; Rosa María Ribas-Aparicio; Juan A Castelán-Vega
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Polymorphisms at residue 222 of the hemagglutinin of pandemic influenza A(H1N1)pdm09: association of quasi-species to morbidity and mortality in different risk categories.

Authors:  Paola Cristina Resende; Fernando C Motta; Maria de Lourdes A Oliveira; Tatiana S Gregianini; Sandra B Fernandes; Ana Luisa F Cury; Maria do Carmo D Rosa; Thiago Moreno L Souza; Marilda M Siqueira
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.